BioRestorative to Present Major Update on Promising Preliminary Phase 2 BRTX-100 Data at ISSCR 2025
– BioRestorative to release new clinical data to the public prior to market open on June 13th –
MELVILLE, N.Y., June 09, 2025 — BioRestorative Therapies, Inc. ('BioRestorative,' 'BRTX' or the 'Company') (NASDAQ:BRTX), a clinical-stage regenerative medicine company developing stem cell-based therapies for serious musculoskeletal conditions, today announced that new preliminary, blinded clinical data from 30 patients enrolled in its ongoing Phase 2 trial of BRTX-100 for the treatment of chronic lumbar disc disease (cLDD) will be presented at the prestigious International Society for Stem Cell Research (ISSCR) 2025 Annual Meeting, held June 11–14, 2025, in Hong Kong.
The highly anticipated presentation will be delivered by Francisco Silva, Vice President of Research and Development at BioRestorative, on Friday, June 13, at 5:00 p.m. HKT, as part of ISSCR 2025's clinical innovations track. The Company will issue a press release pre-market that day, detailing the newly reported data.
'This represents a milestone moment for BioRestorative,' said Lance Alstodt, Chief Executive Officer. 'With preliminary data from twice as many patients as previously shared, we are seeing strong, consistent signals around both safety and functional improvement. We are eager to bring this update to the global scientific community at the world's most influential stem cell conference.'
BRTX-100 is BioRestorative's lead clinical candidate — a hypoxic-cultured, autologous mesenchymal stem cell therapy designed to target areas of the body with limited blood flow, such as damaged spinal discs. The ongoing Phase 2 study is a prospective, randomized, double-blinded, placebo-controlled trial evaluating BRTX-100 in patients with cLDD across up to 16 U.S. clinical sites. A total of 99 patients will be enrolled, randomized 2:1 to receive either BRTX-100 or placebo via a single intradiscal injection.
The presentation, titled 'Stem Cell Therapy for Chronic Lumbar Disc Disease: Phase 2 Clinical Safety and Feasibility Data of Intradiscal Injections of Hypoxic Cultured Mesenchymal Stem Cells,' will highlight key preliminary outcomes focused on patient-reported pain and function metrics, as well as safety endpoints.
About the ISSCR 2025 Annual Meeting
ISSCR 2025 is the largest and most influential gathering of stem cell scientists and regenerative medicine experts globally, attracting nearly 4,000 participants from over 80 countries. It serves as a key venue for groundbreaking clinical and translational research, offering BioRestorative a high-profile platform to share its latest advancements.
For more information on ISSCR 2025, visit www.isscr.org.
About BioRestorative Therapies, Inc.
BioRestorative (NASDAQ:BRTX) is a clinical-stage biotechnology company developing cell-based therapies using adult stem cells to address unmet needs in musculoskeletal and metabolic diseases. The Company's pipeline includes BRTX-100, a novel therapy targeting chronic lumbar disc disease, and ThermoStem ®, a platform focused on brown adipose (fat) biology for the treatment of obesity and metabolic disorders. The Company also operates a commercial BioCosmeceutical platform.
For more information, please visit www.biorestorative.com.
Forward-Looking Statements
This press release contains 'forward-looking statements' within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events or results to differ materially from those projected in the forward-looking statements as a result of various factors and other risks, including, without limitation, those set forth in the Company's latest Form 10-K, filed with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and the Company undertakes no obligation to update such statements.
Contact:
Stephen Kilmer
Investor Relations
Direct: (646) 274-3580
Email: skilmer@biorestorative.com
Featured Image @ Freepik
Read more investing news on PressReach.com.Subscribe to the PressReach RSS feeds:
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CTV News
17 minutes ago
- CTV News
China's fiery baijiu spirit evolves to attract younger drinkers
A worker shows the Green Plum Liqueur, a mix handcrafted single sorghum baijiu with plum juice to reporters during a media organized tour at Jiangxiaobai Liquor Co.'s Jiangji Distillery in southwestern China's Chongqing on May 19, 2025. (AP Photo/Andy Wong) BEIJING (AP) — The centuries-old fiery Chinese spirit baijiu, long associated with business dinners, is being reshaped to appeal to younger generations as its makers adapt to changing times. Mostly distilled from sorghum, the clear but pungent liquor contains as much as 60% alcohol. It's the usual choice for toasts of 'gan bei,' the Chinese expression for bottoms up, and raucous drinking games. 'If you like to drink spirits and you've never had baijiu, it's kind of like eating noodles but you've never had spaghetti,' said Jim Boyce, a Canadian writer and wine expert who founded World Baijiu Day a decade ago. The annual event aims to promote the traditional liquor, which is far less known internationally than whiskey or vodka. Moutai, a kind of baijiu made in mountainous Guizhou province in southwestern China, is known as the country's 'national liquor.' Perhaps its biggest endorsement came in 1974, when U.S. Secretary of State Henry Kissinger banqueted with Deng Xiaoping, who would later become China's top leader. 'I think if we drink enough Moutai, we can solve anything,' Kissinger said. 'Then, when I return to China, we must take steps to increase our production of it,' Deng replied, according to an archived document from the U.S. State Department's Office of the Historian. Price fluctuations of Feitian Moutai, the liquor's most famous brand, serve as a barometer for China's baijiu market. This year, its price has dropped by 36% after four consecutive years of decline, according a report by the China Alcoholic Drinks Association. The report forecast China's baijiu production will likely fall for the eighth straight year in 2025. Baijiu consumption has dropped as people spend more cautiously, cutting back on banquets and drinking due to a weaker economy. Perennial anti-corruption campaigns by the ruling Communist Party targeting lavish official dinners have taken a harsh toll. In May, the party issued new rules banning cigarettes and alcohol during work meals. China's drinking culture is evolving, with younger people keen to protect their health and less inclined to overindulge or be bound by rigid social conventions. Faced with far more choices, they might instead opt for whiskey, wine or non-alcoholic alternatives. 'There is an old saying in China: 'No banquet is complete without alcohol.' It means in the past, without alcohol there is no social lubricant,' 30-year-old Chi Bo said while having cocktails with friends in Beijing's chic Sanlitun area. 'People no longer want to drink alcohol or tend to drink less but they can still sit together and even discuss serious affairs,' Chi said. 'Most of the people don't want to drink alcohol unless they have to.' Baijiu makers are responding with creative innovations like baijiu-flavored ice cream. Kweichou Moutai partnered with China's Luckin' Coffee last year to introduce a Moutai-flavored latte that reportedly sells 5 million cups a day across China. Bartenders also are designing cocktails using a baijiu base. 'There are so many choices right now,' Boyce said. 'It's just about fighting for attention in terms of choice.' Jiangxiaobai, a newer brand made in southwestern China's Chongqing, has targeted young consumers from the beginning. It offers fruit-infused baijiu with an alcohol content below 10%, packaged in smaller, more affordable bottles adorned with philosophical or sentimental phrases meant to resonate with Chinese youth such as, 'Unspoken words. In my eyes, in drafts, in dreams, or downed in a drink.' 'Our promotion of products combines the culture and lifestyle young people advocate,' Jiangxiaobai marketing director Fan Li said. 'From our products to our branding, it's a process of embracing the younger generation.' Shirley Huang, out with friends on a Friday night in Sanlitun, said she had never touched baijiu at age 27, preferring cocktails. But that night, something new on the menu caught her attention: a baijiu-based cocktail. 'Baijiu is quietly making its way into our lives. We just haven't noticed,' she said 'It may not appear as itself, but it reemerges in new forms.' ___ Associated Press video producers Olivia Zhang and Wayne Zhang in Beijing contributed to this report. The Associated Press
CTV News
an hour ago
- CTV News
Japanese game maker Nintendo reports robust profits on strong Switch 2 sales
TOKYO — Nintendo, the Japanese video game maker behind the Super Mario and Pokemon franchises, reported an 18.6% surge in net profit for the first fiscal quarter Friday on the back of strong demand for its new Switch 2 console. Kyoto-based Nintendo Co.'s April-June profit totaled 96.03 billion yen (US$640 million), up from nearly 81 billion yen. Quarterly sales more than doubled to 572.36 billion yen (US$3.8 billion). Nintendo said it sold 3.5 million Switch 2 game consoles globally on the first four days after it hit store shelves June 5, a record pace for a Nintendo game machine. Its sales continue to be strong, it said. The company said the new console's higher price added to sales growth momentum. The new version sells for about $450 compared to $300 for the previous Switch when it first went on sale in 2017, . Especially popular games included 'Mario Kart World' and 'Donkey Kong Bananza.' 'Pokemon Friends,' which went on sale last month for the older Switch, can be also played on the new Switch. The Switch works both as a handheld portable machine and as a home console. Nintendo stuck to its forecast to sell 15 million Switch 2 machines through this fiscal year. Nintendo left unchanged its profit forecast for the year through March 2026, at 300 billion yen (US$2 billion) profit, up nearly 8% on year. Nintendo stock, which has steadily climbed in the past year gaining more than 50%, edged down nearly 1% before earnings were announced. There are some worries about the impact of President Donald Trump's tariffs on Japanese exports, but that did not appear to affect Nintendo's overall projections. Yuri Kageyama, The Associated Press
Globe and Mail
an hour ago
- Globe and Mail
Here's How Trump's Tariffs Could Affect Alibaba Stock
Key Points Alibaba's e-commerce business is relatively (although not completely) tariff-resistant. Tariffs aren't a big issue for Alibaba Cloud, but other U.S. trade policies could be. Alibaba's greatest threat arguably comes from the Chinese government rather than from the U.S. government. 10 stocks we like better than Alibaba Group › New York Times columnist Thomas Friedman wrote in his 2005 best-selling book The World Is Flat that countries are more interconnected than ever before. His premise from 20 years ago is still on target. One downside of this "flat world" is that the trade policies of one country can cause shockwaves for businesses in other countries. We've seen this happen with President Trump's tariffs and threatened tariffs this year. But some businesses and stocks are affected by tariffs less than others. Here's how Trump's tariffs could affect Alibaba Group Holding (NYSE: BABA) stock. E-commerce: Relatively tariff-resistant Guess how many times Alibaba's executives mentioned tariffs during the company's latest quarterly earnings call? Pat yourself on the back if you answered zero. The only reference that came even close was CEO Eddie WU's mention of "potential uncertainties in global trade regulations." I think there's a reason why Alibaba's management didn't focus on tariffs like many of their U.S. counterparts. The company generates around 57% of its total revenue from its e-commerce businesses. However, three-fourths of the company's e-commerce revenue comes from its Taobao and Tmall Group operations. These units serve the Chinese market, which wouldn't be directly affected by U.S. tariffs on Chinese imports. Granted, Alibaba's international digital commerce group contributed roughly 14% of total revenue in the first quarter of 2025. Exactly how much of that revenue stems from the U.S. is uncertain. However, it's fair to say that the company's e-commerce business is relatively (although not completely) tariff-resistant. Perhaps the greatest impact on Alibaba from Trump's tariffs is an indirect one. The Chinese customers and businesses that use its platforms could feel the pain from retaliatory tariffs imposed by the Chinese government on imports from the U.S. Cloud services: Tariffs aren't a big issue Although e-commerce remains Alibaba's biggest revenue source, the company's most important growth driver is its cloud services business. The artificial intelligence (AI) tailwind enjoyed by U.S.-based cloud titans is blowing for Alibaba Cloud, too. Will U.S. tariffs hurt Alibaba Cloud? Probably not much. For one thing, Alibaba doesn't provide cloud services to customers in the U.S. Even if it did, the tariffs discussed so far apply only to imported products but not services. It's possible, though, that U.S. tariffs could hurt some of Alibaba's Chinese business customers and result in their cutting back on spending for cloud services. While tariffs shouldn't be a big issue for Alibaba Cloud, other Trump administration trade policies might be a different story. For example, Nvidia (NASDAQ: NVDA) was temporarily barred from shipping any H20 GPUs to China. Although the White House later allowed the company to resume exporting the chips to China, there's no guarantee that further restrictions won't be imposed. Of course, Alibaba could use other chips to power AI applications. However, Nvidia is an important partner and will likely continue to be as long as its GPUs remain the gold standard for training and deploying AI models. Overall tariff impact on Alibaba When all things are considered, President Trump's tariffs could affect Alibaba in some ways, but the Chinese tech giant should be largely unscathed. This assumes, though, that the final tariffs levied on China don't go radically beyond what has been proposed thus far. Alibaba's greatest threat arguably comes from the Chinese government rather than from the U.S. government. The company's 20-F filing to the U.S. Securities and Exchange Commission acknowledges several ways the government in its home country could negatively affect its business. These risks are partly to blame for Alibaba's low valuation. Its shares trade at only 14.3 times forward earnings, a much lower multiple than the company's U.S. counterparts. I think this valuation makes the stock a solid pick for long-term investors who aren't overly risk-averse. Should you invest $1,000 in Alibaba Group right now? Before you buy stock in Alibaba Group, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Alibaba Group wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $638,629!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,098,838!* Now, it's worth noting Stock Advisor's total average return is 1,049% — a market-crushing outperformance compared to 182% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 29, 2025
